“showed a trend”

The same was true for hiPSC line CaSR, except for the fact that Perimeter only showed a trend towards statistical significance ( p = 0.07).

The statistically significant predictors of the primary endpoint at univariate analysis are presented in Table 2 (univariate analysis showed a trend towards statistical significance of the cardiopulmonary bypass time parameter for the primary endpoint, p = 0.07).

The MSS- RNF43 mutated subtype also showed a trend toward better OS compared to the MSS- RNF43 wild-type subtype (mOS of 13.6 versus 7 months; P = 0.07; HR, 0.46; 95% CI, 0.20–1.08; Fig. 3c,d and Extended Data Fig. 6c,d ).

These patients showed a trend towards more vessel inflammation in the muscle biopsy (10% vs 1%, P = 0.07), less myalgia (33% vs 54%, P = 0.07), lower CK median levels (459 vs 823, P = 0.06) and lower cellularity in the biopsy characterized by less CD68 + (68% vs 85%, P = 0.07) and CD45 + cells (64% vs 79%, P = 0.10) when compared with the anti-FHL1 – counterpart ( Supplementary Table S3 , available at Rheumatology online).

Patients with concurrent pelvic nodal recurrence showed a trend towards worse OS (HR = 2.1, 95% CI: 0.9-4.8, p = 0.07).

Patients who required redosing showed a trend toward a higher baseline CRT as compared with patients who did not yet require additional doses (634.5 μ m [IQR, 207] vs. 573.0 μ m [IQR, 195]; p = 0.07, Table 2 ).

Pre-specified analysis of HPS2-THRIVE based on sex showed a trend towards worse CV outcomes in women treated with niacin ( p = 0.07).

The coefficient of variation showed a trend towards lower glucose variability during treatment with dapagliflozin as compared with placebo (33.6 ± 0.0 vs. 36.9 ± 0.0%, p = .07).

Some items showed a trend for significance, such as the 2 to 6-months hearing response ( P = .07), positioning of the legs in supine and standing positions ( P = .09), and hip adductors at 7–12 months ( P = .09).

The posited PRS-7 showed a trend (OR 1.56, 95% CI 0.92–2.56, p = 0.070), and sensitivity analysis comprising three variants (PRS-3) was significantly associated with GDM (OR 2.43, 95% CI 1.17–5.06, p = 0.017).

The female rats showed a trend toward a vendor by apomorphine interaction ( p =0.07).

Patients with no relevant hypoxia (HSV <1 mL) at baseline (n = 6) showed a trend towards decreased osteopontin levels compared to patients with hypoxic tumors (55.3 vs. 84.5 ng/mL, p = 0.07).

Analysis of outcomes performed during the 30-day postoperative period showed a trend toward shorter average length of stay in endoscopic group (P=0.07).

Federation of Gynecology and Obstetrics stage showed a trend with miR-1-3p ( p = 0.070, η2 = 0.333), suggesting higher expression in advanced stages.

While there was no significant difference in reducing overall disability compared to no thrombolysis, the effect estimate showed a trend favoring Tenecteplase (gOR 1.28, CI 0.98–1.67; p = 0.07; I 2 = 0%) ( Figure 3 ). 4.

It showed a trend toward worse cardiac outcomes in the diabetic subgroup after liraglutide administration (HR = 1.54, p = 0.07), while there was no significant difference in the number of deaths or re-hospitalizations for HF in individuals without diabetes between the liraglutide group and the placebo group (HR = 1.02, p = 0.94) [ 147 ].

The meta-analysis showed a trend towards statistical significance between the experimental and control groups (−0.53, 95% CI [−1.11 to 0.05]; p = 0.07; I 2 = 86%) ( Figure 7 ).

The LAAO group showed a trend toward having a lower estimated mRS scores at baseline to those of the NOAC group (p=0.07) and scores at 12 months post-stroke were significantly lower in the LAAO group (p<0.01), even after adjusting for several variables, including CHA 2 DS 2- VASc score, HAS-BLED score, age, gender, and other cardiovascular risk factors.

However, numbers of patients reaching the threshold for HADS-Anxiety doubled, which showed a trend (5 (13.5%) vs. 10 (27.03%), p = 0.07).

Positive PD-L1 staining determined at a threshold of 1% showed a trend towards improved survival in the entire cohort (70.3% vs. 57.4%, p = 0.07) in univariate analysis ( Figure 2 ).

A larger ratio of ascending aorta length to diameter ratio in relation to the sheath size corrected by body surface area showed a trend toward developing HITS ( P = .07) ( Table 6 ).

In the A-not-B task, only ruffed lemurs preferentially selected the correct container at an above-chance level on test trials ( p < .05), and performance of mongoose lemurs showed a trend toward doing so ( p = .07); performance of ring-tailed lemurs and sifakas did not differ from chance (for details, see Fig. 2b and the Supplemental Material ).

We found a trend towards an increase in the TNFR1 + classical monocyte cell population [Ctl: 1.87% (1.21–2.52) and IS: 2.54% (2.07–4.27), U = 51.5, p = 0.07] in ischemic stroke patients compared to controls, whereas the TNFR1 + intermediate cell population showed a trend towards a decrease [Ctl: 1.35% (0.44–2.52) and IS: 0.49% (0.13–1.04), U = 52, p = 0.07] ( Figure 3 f).

In contrast, dietary DDGS showed a trend to increase ( p < 0.07) HC (25.53 vs. 24.6 kg; Figure 5 ), CC (21.1 vs. 19.8 kg), and ( p < 0.08) MC a (16.59 vs. 16.3) relative to the control across comparisons.

However, the mortality RR from six inpatient studies also showed a trend of increased mortality with HCQ with pooled RR of 1.09 (95% CI 0.99–1.20, I 2 = 0%, p = 0.07; Figure S2 ).